Narrative Review of Management Strategies and Risk Mitigation for Gastrointestinal Bleeding in Atrial Fibrillation Patients Receiving Warfarin
Clinical and Applied Thrombosis/Hemostasis
Published online on January 12, 2026
Abstract
Clinical and Applied Thrombosis/Hemostasis, Volume 32, January-December 2026.
A globally prevalent cardiac arrhythmia, atrial fibrillation (AF) greatly increases the risk of thromboembolic events, making effective anticoagulation necessary. The mainstay of this treatment has long been the vitamin K antagonist warfarin. However, ...
A globally prevalent cardiac arrhythmia, atrial fibrillation (AF) greatly increases the risk of thromboembolic events, making effective anticoagulation necessary. The mainstay of this treatment has long been the vitamin K antagonist warfarin. However, ...